PHAT icon

Phathom Pharmaceuticals

84 hedge funds and large institutions have $220M invested in Phathom Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.81M
Puts
$16K
Net Calls
Net Calls Change

Top Buyers

1 +$20.9M
2 +$1.7M
3 +$1.43M
4
NM
Newtyn Management
New York
+$1.41M
5
Bank of America
Bank of America
North Carolina
+$1.34M

Top Sellers

1 -$2.64M
2 -$1.64M
3 -$657K
4
BlackRock
BlackRock
New York
-$439K
5
Invesco
Invesco
Georgia
-$185K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$60M
2
$20.9M
3
$17.7M
4
$15.6M
5
$14.6M
6
$12.6M
7
$11.7M
8
$9.46M
9
$8.41M
10
$4.87M
11
$4.28M
12
$3.95M
13
$3.54M
14
$3.31M
15
$3.2M
16
$3.01M
17
$1.81M
18
$1.7M
19
$1.52M
20
$1.52M
21
$1.43M
22
$1.35M
23
$1.23M
24
$1.05M
25
$954K